Condition: Hepatocellular Carcinoma · Sponsor: Chinese Academy of Sciences
This study is to evaluate whether intraoperative fluorescence imaging targeting GPC3 can aid improve the surgical accuracy of hepatocellular carcinoma. The main purposes of this study include: ① To raise the detection rate of hepatocellular carcinoma intraoperatively using the novel NIR-II fluorescence molecular imaging and the GPC-3 targeted fluorophore. ② To validate the safety and effectiveness of the designed GPC-3 targeted fluorophore for clinical application.
This description comes directly from the study's public registry record.
Zeyu Zhang, Ph.D. · 86-18201082715 · zhangzeyu@fingerpass.net.cn
Always discuss trial participation with your own doctor first.
| Zhuhai People's Hospital | Zhuhai, Guangdong, China | Recruiting |
| The Affiliated Hospital of Southwest Medical University | Luzhou, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05047510